Diagnostic and Biotech

New Frontiers in the French Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape

  • VPG16141
  • 0 Pages
  • May 2014
  • Diagnostic and Biotech

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.


New Frontiers in the French Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities and develop effective strategies for the French coagulation testing market during the next five years.


The report explores business and technological trends in the French coagulation testing market; provides estimates of the test volume, as well as sales and market shares for leading instrument and reagent competitors; compares features of major analyzers; profiles leading market players; analyzes potential applications of emerging technologies; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.


Rationale


The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the German coagulation diagnostics practice during the next five years. New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.


French Market Overview

- Comprehensive market segmentation analysis, including review

of the market dynamics, structure, size, growth and major suppliers.


- Estimated universe of facilities performing coagulation tests.


- Five-year test volume and sales projections.


Business Opportunities and Strategic Recommendations


- Product development and business expansion

opportunities with significant market appeal.


- Ideal product models with tentative

prices and operating characteristics.


- Alternative market penetration

strategies for instrument and reagent suppliers.


- Potential market entry barriers and risks.


Current and Emerging Coagulation Tests


Activated Clotting Time (ACT) (1), Activated Protein C Resistance,

Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,

D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX,

Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,

Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,

Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,

Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,

Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time,

Von Willebrand's Factor Fav/Ag, and others.


Sales and Market Share Analysis of Instrument and Reagent Suppliers


- Sales and market shares of major instrument

and consumable manufactures.


Market Segmentation Analysis


- Comprehensive market

segmentation analysis, including:


- Hospitals

- Commercial/Private Laboratories


- Test volume forecasts for over 40 major procedures,

by market segment.


Current and Emerging Products


- Review of established and new procedures.


- Comparison of automated and semi-automated

analyzers marketed by Diagnostica Stago, Helena, IL,

Roche, Siemens, Sysmex and other suppliers.


Technology Review


- Analysis of current and emerging technologies

and their potential market applications.


- Comprehensive lists of companies developing

or marketing new technologies and products by test.


Competitive Strategies


- Strategic assessments ofmajor suppliers and start-up firms

developing innovative coagulation testing technologies

and products, including their sales, product portfolios,

marketing tactics, collaborative arrangements, and new products in R&D.


- The companies analyzed in the report include:


- Abbott

- ADI/American Diagnostica

- Axis-Shield

- Alere/Biosite/Inverness

- Beckman Coulter/Danaher

- Becton Dickinson

- Bio/Data

- Chrono-Log

- Corgenix Medical

- Diagnostica Stago/Trinity Biotech

- Grifols

- Helena Laboratories

- Hyphen BioMed

- Instrumentation Laboratory

- ITC/Nexus Dx

- Roche

- Siemens

- Sienco

- Sysmex

- Thermo Fisher

- ZyCare/Alere


Contains 405 pages and 35 tables

Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

World Live Cell Imaging Market - Opportunities and Forecast, 2014 - 2020

Live cell imaging is the study of cells in real time using the images obtained from screening systems and microscopes. The technology has altered the approach of scientists to study ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Malaria Diagnostics Market (Technique and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Malaria is caused by the Plasmodium parasites and is transmitted by the female anopheles mosquito. Diagnosis of malaria includes detection by microscopy and blood tests. According to the WHO, in ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Label Free Detection Market (Technology, Product, Application, End User and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast 2013 - 2020

The label free detection method is used for detecting biomolecules and their interactions. This method has emerged as an attractive research and development tool in the pharmaceutical and biotech industry. Partnerships between pharmaceutical companies and academic institutes and the rising number of drug discovery programs will boost market growth.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Therapies and Diagnostics for Cervical Cancer Market, (Types, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Cancer has been globally affecting 10million people and it is expected to increase by 2.4% by 2020, reaching to 14 million. Cervical Cancer is a form of cancer that forms ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Exocrine Pancreatic Insufficiency Market (Mode of Disease management, Type of diagnostic tests and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021

Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas. EPI is commonly found in humans affected with Shwachman-Diamond ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Respiratory Syncytial Virus (RSV) Diagnostic Market (Technology, End Users and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Respiratory syncytial virus (RSV) is a virus which causes respiratory infections such as bronchiolitis and pneumonia. Globally, the cases of RSV infections are on the rise which is fueling the ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>